Načítá se...
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
Bipolar disorder is a serious psychiatric condition that has been treated for over fifty years with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor, suggesting that manipulating GSK-3 may have therapeutic value in treating bipolar disorder. GSK-3 is regulated by a...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2020444/ https://ncbi.nlm.nih.gov/pubmed/17499358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neubiorev.2007.03.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|